BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 3c
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.32, $0.03 better than the analyst estimate of $0.29. Revenue for the quarter came in at $124.8 million versus the consensus estimate of $118.98 million.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
BioMed Realty Trust, Inc. sees FY2012 FFO of $1.20-$1.28, versus the consensus of $1.24.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.